Regeneron Pharmaceuticals Inc. (REGN)

All Comments on REGN

  • commenter
    Alan
    Brochstein
    Jun 18 12:54 PM
    My Website
    Cancer Stocks Slide Again [view article]
    I wanted to point out an error in the article - GNVC is developing a pancreatic cancer treatment (not vaccine). Reply
  • commenter
    Alan
    Brochstein
    Jun 11 02:51 PM
    My Website
    Cancer Stocks Plunge Following ASCO Meeting [view article]
    Miles, I have a negative bias towards small biotech companies, especially ones like this that have a terrible history of underperforming the stock market, generating losses and diluting with equity issuance. That isn't to say that one might find a diamond in the garbage can, but, I think that one is actually more likely to find a diamond in the garbage can. If one of these companies is creating a truly novel, revolutionary treatment, I personally believe that an investor would have plenty of time to buy later at a higher price and still make a ton of money.

    Note, I don't have an opinion specifically on Insmed other than my general observations in the above paragraph.     Reply
  • commenter
    milesjrobert
    s
    Jun 11 12:00 PM
    Cancer Stocks Plunge Following ASCO Meeting [view article]
    Dear Sir,
    What is your current opinion on Insmed?
    Thank you very much,
    Miles Roberts     Reply
  • commenter
    Mr Mister
    Jun 04 06:00 PM
    Cancer Stocks Soar With Annual ASCO Meeting [view article]
    Your table is too over-crowded to be useful. Next time skip the industry, HQ city and state as it is meaningless except for job seekers. Nice try though. Reply
  • commenter
    Alan
    Brochstein
    May 30 05:14 AM
    My Website
    Cancer Stocks on the Go: Winners and Losers [view article]
    You get what you pay for, then. If I could publish this list in advance, well, I would be doing it from my boat in the Bahamas!

    Many investors look at price action in order to alert them to areas where they should be focused. Is the move overdone (take profits), or is it sustainable (consider buying).     Reply
  • commenter
    pavlov
    May 29 11:54 PM
    Cancer Stocks on the Go: Winners and Losers [view article]
    Telling me about stocks after the fact don't do shit for me!!! Reply
  • commenter
    marcel.tony
    Apr 02 10:22 AM
    Biotech Day In Review: Novartis Pulls Zelnorm Off The Market [view article]
    Astellas is quite right : REGN has fantastic monoclonal technology. Rather than manipulate the Fc fragment, they know how to manipulate the moieties of the receptors linked to it. This is unique.
    Have a look at a picture that hopefully makes this a bit more simple to understand :
    www.healthvalue.net/VE...     Reply
  • commenter
    jturano7423
    Apr 01 09:53 AM
    Jim Cramer's Mad Money In-Depth Stock Picks, March 16 [view article]
    I read an article regarding recent comments that Jim Crammer made and that it's now being reviewed.
    It regarded something to the effect of touting stocks and mutual fund managers taking advantage of the touts.
    Although it may be illegal but that it has been done before in the industry. I'm sure nothing will come of it.
    But in retrospect, maybe that's why a particular stock was mentioned , and that investors should buy it, because it could be a potential winner down the road. Not mentioning the stock in particular, but with poor ratings,poor fundamentals,earnings,... payments by partnership company, raising millions in new stock offerings
    followed by raises in pay, and new options granted, and only a one product pipeline, one has to seriously consider the main reason of a t.v.celebrity touting a stock that does not warrant at this current time, an investment to be made and parked for a long period of time, as he suggests. "very suspicious!
    jt7423     Reply

Trading Center


Loading...
Symbols:
Authors:
Quick Links: